Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients

Objective This study aimed to find the effect of serum Cystatin C in early diabetic nephropathy. Method This study was conducted in Al Kindy Teaching Hospital during the period from December, 2015 to June, 2016. The study included 90 subjects (30 males and 30 females) with diabetic type 2 and 30 hea...

Full description

Bibliographic Details
Main Authors: Ahmed Abed Kadhem Al-Saedy, Kismet M. Turki, Shaymaa Z. Nadaa
Format: Article
Language:English
Published: Nab'a Al-Hayat Foundation for Medical Sciences and Health Care - Press 2017-06-01
Series:Journal of Contemporary Medical Sciences
Online Access:http://www.jocms.org/index.php/jcms/article/view/152
_version_ 1811262997398552576
author Ahmed Abed Kadhem Al-Saedy
Kismet M. Turki
Shaymaa Z. Nadaa
author_facet Ahmed Abed Kadhem Al-Saedy
Kismet M. Turki
Shaymaa Z. Nadaa
author_sort Ahmed Abed Kadhem Al-Saedy
collection DOAJ
description Objective This study aimed to find the effect of serum Cystatin C in early diabetic nephropathy. Method This study was conducted in Al Kindy Teaching Hospital during the period from December, 2015 to June, 2016. The study included 90 subjects (30 males and 30 females) with diabetic type 2 and 30 healthy control. Age is between 30 and 70 years. Patients were with no history of liver disease, thyroid or other endocrine diseases through clinical interviewing. They were divided in to three groups. 30 healthy controls, 30 patients with type 2 diabetes mellitus with no albuminuria (albumin excretion in urine <30 μg/ml ) and 30 patients with type 2 diabetes mellitus with micro albuminuria (albumin excretion in urine >30 μg/ml ). Results There were no significant differences in age, body mass index (BMI) among the studied groups (p > 0.05). Serum Cystatin C levels showed significant difference (p < 0.001) among studied groups, it was significantly higher in micro albuminuria than the other two groups. There was highly significant positive correlation between Cystatin C and serum creatinine (r = 0.697, p < 0.001), and a significant negative correlation between Cystatin C and GFR (r = − 0.455, p = 0.011) and show significant positive correlation between Cystatin C and urine albumin (r = 0.526, p = 0.003 ) in type 2 diabetic patients with micro albuminuria. Conclusion Cystatin C is negatively correlated with the amount of GFR, so that Cystatin C considered reliable and sensitive marker for identifying changes in GFR. In type 2 diabetes mellitus with micro albuminuria serum Cystatin C level considered predict marker for renal failure.
first_indexed 2024-04-12T19:37:03Z
format Article
id doaj.art-ed69b12eea65467fb0713e270649a2c5
institution Directory Open Access Journal
issn 2415-1629
2413-0516
language English
last_indexed 2024-04-12T19:37:03Z
publishDate 2017-06-01
publisher Nab'a Al-Hayat Foundation for Medical Sciences and Health Care - Press
record_format Article
series Journal of Contemporary Medical Sciences
spelling doaj.art-ed69b12eea65467fb0713e270649a2c52022-12-22T03:19:11ZengNab'a Al-Hayat Foundation for Medical Sciences and Health Care - PressJournal of Contemporary Medical Sciences2415-16292413-05162017-06-01310152Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patientsAhmed Abed Kadhem Al-Saedy0Kismet M. Turki1Shaymaa Z. Nadaa2Department of Biochemistry, College of Medicine, University of Karbala, Holy Karbala cityDepartment of Biochemistry, College of Medicine, University of Baghdad, BaghdadDepartment of Biochemistry, College of Medicine, University of KerbalaObjective This study aimed to find the effect of serum Cystatin C in early diabetic nephropathy. Method This study was conducted in Al Kindy Teaching Hospital during the period from December, 2015 to June, 2016. The study included 90 subjects (30 males and 30 females) with diabetic type 2 and 30 healthy control. Age is between 30 and 70 years. Patients were with no history of liver disease, thyroid or other endocrine diseases through clinical interviewing. They were divided in to three groups. 30 healthy controls, 30 patients with type 2 diabetes mellitus with no albuminuria (albumin excretion in urine <30 μg/ml ) and 30 patients with type 2 diabetes mellitus with micro albuminuria (albumin excretion in urine >30 μg/ml ). Results There were no significant differences in age, body mass index (BMI) among the studied groups (p > 0.05). Serum Cystatin C levels showed significant difference (p < 0.001) among studied groups, it was significantly higher in micro albuminuria than the other two groups. There was highly significant positive correlation between Cystatin C and serum creatinine (r = 0.697, p < 0.001), and a significant negative correlation between Cystatin C and GFR (r = − 0.455, p = 0.011) and show significant positive correlation between Cystatin C and urine albumin (r = 0.526, p = 0.003 ) in type 2 diabetic patients with micro albuminuria. Conclusion Cystatin C is negatively correlated with the amount of GFR, so that Cystatin C considered reliable and sensitive marker for identifying changes in GFR. In type 2 diabetes mellitus with micro albuminuria serum Cystatin C level considered predict marker for renal failure.http://www.jocms.org/index.php/jcms/article/view/152
spellingShingle Ahmed Abed Kadhem Al-Saedy
Kismet M. Turki
Shaymaa Z. Nadaa
Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
Journal of Contemporary Medical Sciences
title Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
title_full Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
title_fullStr Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
title_full_unstemmed Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
title_short Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients
title_sort effect of serum cystatin c in early diabetic nephropathy in type 2 iraqi diabetic patients
url http://www.jocms.org/index.php/jcms/article/view/152
work_keys_str_mv AT ahmedabedkadhemalsaedy effectofserumcystatincinearlydiabeticnephropathyintype2iraqidiabeticpatients
AT kismetmturki effectofserumcystatincinearlydiabeticnephropathyintype2iraqidiabeticpatients
AT shaymaaznadaa effectofserumcystatincinearlydiabeticnephropathyintype2iraqidiabeticpatients